Compare CUE & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CUE | HUBC |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 25.0M |
| IPO Year | 2017 | N/A |
| Metric | CUE | HUBC |
|---|---|---|
| Price | $0.29 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 386.2K | 185.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,287,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 69.16 | N/A |
| 52 Week Low | $0.23 | $0.29 |
| 52 Week High | $1.26 | $5.09 |
| Indicator | CUE | HUBC |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 40.69 |
| Support Level | $0.28 | $0.89 |
| Resistance Level | $0.36 | $2.04 |
| Average True Range (ATR) | 0.02 | 0.32 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 29.81 | 23.30 |
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.